Cardiac CT Angiography (CCTA) is growing as it should. As with any new applications in diagnostic medicine there are incidences of inappropriate use. However, the ability for this technology to identify those without significant coronary artery disease (CAD) is significant. The test is less expensive than cardiac catheterization and certainly brings with it much lower risk. CCTA is here to stay for screening those suspected of CAD and possibly needing intervention. With the increasing numbers of cardiology practices joining hospitals the use of this application will grow and its appropriate use will become more apparent to those who order the test.
http://www.